Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
Eli Lilly
LLY
$1.08T
| $378M | 0.1% |
1,165,085
+1,123,361
| +2,692% | +$337M |
|
127
CALL
Wells Fargo
WFC
$264B
| $375M | 0.1% |
9,578,500
+2,950,000
| +45% | +$129M |
|
128
PUT
Amgen
AMGN
$224B
| $374M | 0.1% |
1,536,900
+462,000
| +43% | +$113M |
|
129
Home Depot
HD
$353B
| $370M | 0.09% |
1,348,823
+234,816
| +21% | +$69.3M |
|
130
PUT
Li Auto
LI
$12.4B
| $368M | 0.09% |
9,594,800
+1,908,500
| +25% | +$51M |
|
131
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.67B
| $365M | 0.09% |
3,058,900
+1,312,000
| +75% | +$184M |
|
132
PUT
Johnson & Johnson
JNJ
$626B
| $365M | 0.09% |
2,058,800
-41,400
| -2% | -$7.38M |
|
133
Charter Communications
CHTR
$18.8B
| $364M | 0.09% |
777,325
+245,508
| +46% | +$120M |
|
134
CALL
Intuit
INTU
$92B
| $363M | 0.09% |
941,200
+404,600
| +75% | +$168M |
|
135
PUT
Visa
V
$677B
| $362M | 0.09% |
1,840,700
-959,600
| -34% | -$198M |
|
136
CALL
Coca-Cola
KO
$372B
| $354M | 0.09% |
5,634,000
+750,600
| +15% | +$47.6M |
|
137
CALL
Occidental Petroleum
OXY
$59B
| $353M | 0.09% |
5,987,700
+658,700
| +12% | +$40.5M |
|
138
PUT
AutoZone
AZO
$49.7B
| $352M | 0.09% |
163,600
+58,300
| +55% | +$120M |
|
139
PUT
McDonald's
MCD
$194B
| $351M | 0.09% |
1,420,700
+663,400
| +88% | +$163M |
|
140
PUT
Lam Research
LRCX
$390B
| $350M | 0.09% |
8,216,000
+254,000
| +3% | +$12.1M |
|
141
Cigna
CI
$72.4B
| $349M | 0.09% |
1,325,173
-41,668
| -3% | -$10.7M |
|
142
PUT
Starbucks
SBUX
$122B
| $349M | 0.09% |
4,569,500
+1,194,100
| +35% | +$91.7M |
|
143
Microsoft
MSFT
$3.74T
| $349M | 0.09% |
1,359,102
+987,547
| +266% | +$268M |
|
144
PUT
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $348M | 0.09% |
8,681,500
+3,717,900
| +75% | +$156M |
|
145
CALL
Target
TGT
$69.2B
| $346M | 0.09% |
2,451,500
+1,258,700
| +106% | +$241M |
|
|
146
PUT
Cigna
CI
$72.4B
| $345M | 0.09% |
1,310,900
+584,200
| +80% | +$151M |
|
147
PUT
Lockheed Martin
LMT
$138B
| $339M | 0.09% |
788,900
-482,500
| -38% | -$212M |
|
148
CALL
Moderna
MRNA
$24.2B
| $338M | 0.09% |
2,368,900
-1,349,600
| -36% | -$193M |
|
149
CALL
TSMC
TSM
$2.19T
| $337M | 0.09% |
4,117,100
+168,800
| +4% | +$15.6M |
|
150
PUT
CrowdStrike
CRWD
$226B
| $336M | 0.09% |
7,968,800
-1,005,200
| -11% | -$45.5M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.